Wei, Shuo
Kozono, Shingo
Kats, Lev
Nechama, Morris
Li, Wenzong
Guarnerio, Jlenia
Luo, Manli
You, Mi-Hyeon
Yao, Yandan
Kondo, Asami
Hu, Hai
Bozkurt, Gunes
Moerke, Nathan J
Cao, Shugeng
Reschke, Markus
Chen, Chun-Hau
Rego, Eduardo M
Lo-Coco, Francesco
Cantley, Lewis C
Lee, Tae Ho
Wu, Hao
Zhang, Yan
Pandolfi, Pier Paolo
Zhou, Xiao Zhen
Lu, Kun Ping
Article History
Received: 5 December 2014
Accepted: 16 March 2015
First Online: 13 April 2015
Competing interests
: K.P.L. and X.Z.Z. are the inventors of Pin1 inhibition technology, which was licensed by BIDMC to Pinteon Therapeutics. K.P.L. and X.Z.Z. own equity in and consult for Pinteon. K.P.L. also serves on its board of directors. Their interests were reviewed and are managed by BIDMC in accordance with its conflict of interest policy.